The University of Vermont Health Network
VC Fund
Burlington, United States
The University of Vermont Health Network is a VC fund in Burlington focused on Medical and Health Care. Welcome to The University of Vermont Health Network, five partner hospitals serving the residents of Vermont and northern New York. With over 4,000 health care providers throughout our region, they work together to offer high-quality care more cost-efficiently and as close to home as possible. Strengthened by their connection, each of theirhospitals remains committed to its local community and to the heart and science of medicine: compassionate, personal care shaped by the latest medical advances and delivered by highly skilled experts.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries The University of Vermont Health Network invests in
Stages The University of Vermont Health Network invests in
Countries The University of Vermont Health Network invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Medical 2 (50%)
- Health Care 2 (50%)
- Therapeutics 2 (50%)
- Biotechnology 2 (50%)
- Fashion 1 (25%)
Stage
- Seed 1 (25%)
- Series A 1 (25%)
- Series B 1 (25%)
- Venture - Series Unknown 1 (25%)
Country
- United States 2 (50%)
- France 1 (25%)
- Ireland 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Benjamin Littenberg
Attending Physician
|
Attending Physician | Total investments: 0 | Find email | |
Charlie Miceli
Vice President Network Chief Supply Chain Officer
|
Vice President Network Chief Supply Chain Officer | Total investments: 0 | Find email | |
Heather Roszkowski
Chief Information Security Officer
|
Chief Information Security Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| CILcare specializes in providing drug solutions for hearing and ear disorders. | $42M / Series A / Dec 04, 2024 | ||
| THEYA Healthcare is a multi-award winning medical device company that designs and manufactures innovative post surgery garments scientifically proven to soothe and speed up healing. The company was founded by entrepreneur, Ciara Donlon, after she discovered a gap in the post surgery lingerie market whilst running her own successful lingerieretail business in Dublin. Women undergoing treatment for breast cancer would regularly ask her to find comfortable, feminine underwear that met their needs, but Ciara quickly realised that such a product didn't exist. After conducting research with 80 breast cancer survivors and putting their valuable insight at the centre of the design process, Ciara launched Theya Healthcare's flagship post surgery range of underwear in 2015. Theya Healthcare uses a unique bamboo mix fabric which has been scientifically proven 92-97% antibacterial as well as 59% more absorbent and 19% better at wicking moisture away from the skin than cotton. The unique design features of the range were put to the test in a clinical trial across four Dublin teaching hospitals and Theya Healthcare’s range outperformed competing products in terms of Body Image, Health Status and Pain. Patients wearing Theya Healthcare bras in the four week post surgery recovery phase experienced an 8.5% improvement in Body Image, a 20% improvement in Health Status and a reduction in levels of irritation, wound discomfort and pain. The results for competing products over the same timeframe showed a 9.5% deterioration in Body Image, only an 8% improvement in Health Status and increased pain levels in the region of patients’ scars.Since Theya Healthcare began trading in 2015, its founder and CEO, Ciara Donlon, has been recognised by numerous awards, including winning the prestigious Cartier Women's Initiative Award and being listed as a finalist in the EY Entrepreneur of the Year in 2017. | $593.2K / Venture - Series Unknown / Jun 18, 2021 | ||
| Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients. | $5.4M / Seed / Sep 05, 2019 | ||
| BioFactura has developed the StableFast™ Biomanufacturing Platform, a novel system to rapidly generate stable NS0 cell lines for biopharmaceutical manufacturing. The elements of this system include a chemically-defined, serum- and cholesterol-free production medium and pre-adapted parental cells, modular expression vectors that utilize a patentedselection strategy, and a proprietary growth supplement that permits rapid generation and cloning of cell lines. This platform is simple to use, fast, and productive. A clonal production cell line can be developed and scaled up to yield over one gram of product in less than eight weeks. | $6M / Series B / Apr 29, 2019 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does The University of Vermont Health Network invest in?
The University of Vermont Health Network invests primarily in Medical, Health Care and Therapeutics startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact The University of Vermont Health Network?
Public channels for The University of Vermont Health Network include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at The University of Vermont Health Network?
The team at The University of Vermont Health Network includes Benjamin Littenberg (Attending Physician), Charlie Miceli (Vice President Network Chief Supply Chain Officer) and Heather Roszkowski (Chief Information Security Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
